Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESTRO 2022 | How can we optimise the use of patient reported outcomes in clinical practice?

Pedro Lara • 16 May 2022
ESTRO 2022
General

Pedro Lara, MD, PhD, Fernando Pessoa Canarias University and San Roque University Hospital, Gran Canarias, Spain, discusses how to optimise the collection and use of patient reported outcomes (PROs), as well as highlighting the challenges that need to be overcome in this area. This interview took place at the European Society for Radiotherapy and Oncology (ESTRO) 2022 annual congress in Copenhagen, Denmark, and online.

More from Pedro Lara

1:01
Highlights in breast and gynecological cancer at ESTRO 2022
Pedro Lara • 17 May 2022
1:17
The importance of Patient Reported Outcomes in clinical trials
Pedro Lara • 16 May 2022

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals